RT Journal Article
SR Electronic
T1 Inadequate intention to receive Covid-19 vaccination: indicators for public health messaging needed to improve uptake in UK
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.07.20243881
DO 10.1101/2020.12.07.20243881
A1 Bachtiger, Patrik
A1 Adamson, Alexander
A1 Maclean, William A
A1 Quint, Jennifer K
A1 Peters, Nicholas S
YR 2020
UL http://medrxiv.org/content/early/2020/12/08/2020.12.07.20243881.abstract
AB Data promising effective Covid-19 vaccines have accelerated the UK’s mass vaccination programme. The UK public’s attitudes to the government’s prioritisation list are unknown, and achieving critical population immunity will require the remaining majority to accept both vaccination and the delay in access of up to a year or more. This cross-sectional observational study sent an online questionnaire to registrants of the UK National Health Service’s largest personal health record. Question items covered willingness for Covid-19 vaccine uptake and attitudes to prioritisation. Among 9,122 responses, 71.5% indicated wanting a vaccine, below what previous modelling indicated as critical levels for progressing towards herd immunity. 22.7% disagreed with the prioritisation list, though 70.3% were against being able to expedite vaccination through payment. Age and female gender were, respectively, strongly positively and negatively associated with wanting a vaccine. Teachers and Black, Asian and Minority Ethnic (BAME) groups were most cited by respondents for prioritisation. This study identifies factors to inform the public health messaging critical to improving uptake.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by: Imperial Health Charity, Imperial Biomedical Research Centre of the National Institute of Health Research, British Heart Foundation, Pfizer Independent Grants, NHSX and Rosetrees Foundation. This work is supported by BREATHE - The Health Data Research Hub for Respiratory Health [MC_PC_19004]. BREATHE is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The institutional review board (Imperial College Healthcare NHS Trust Data Protection Office) approved this study and advised ethical approval for data analysis and publication was not required. Participants were informed prior to completing responses that these would be anonymised to inform local and national health policy and were free to opt out.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesImperial College Healthcare NHS Trust is the data controller. The datasets analysed in this study are not publicly available but can be shared for scientific collaboration subject to meeting requirements of the institution's data protection policy.